Works matching IS 00333158 AND DT 2023 AND VI 240 AND IP 6


Results: 16
    1

    Phosphodiesterase inhibitors in psychiatric disorders.

    Published in:
    Psychopharmacology, 2023, v. 240, n. 6, p. 1201, doi. 10.1007/s00213-023-06361-3
    By:
    • Sadeghi, Mohammad Amin;
    • Nassireslami, Ehsan;
    • Yousefi Zoshk, Mojtaba;
    • Hosseini, Yasaman;
    • Abbasian, Kourosh;
    • Chamanara, Mohsen
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16

    Chronic H<sub>3</sub>R activation reduces L-Dopa-induced dyskinesia, normalizes cortical GABA and glutamate levels, and increases striatal dopamine D<sub>1</sub>R mRNA expression in 6-hydroxydopamine-lesioned male rats.

    Published in:
    Psychopharmacology, 2023, v. 240, n. 6, p. 1221, doi. 10.1007/s00213-023-06339-1
    By:
    • Avila-Luna, Alberto;
    • Gálvez-Rosas, Arturo;
    • Aguirre-Pérez, Alexander;
    • Hidalgo-Bravo, Alberto;
    • Alfaro-Rodriguez, Alfonso;
    • Ríos, Camilo;
    • Arias-Montaño, José-Antonio;
    • Bueno-Nava, Antonio
    Publication type:
    Article